A 12-week randomized trial demonstrated: Average weight loss of 2.6 kg in AOD-9604 group (1 mg/day) versus 0.8 kg in placebo group Preferential reduction in abdominal and visceral fat deposits No adverse effects on carbohydrate metabolism or insulin sensitivity Non-dose-dependent effects, with higher doses (10 mg/day) producing less weight loss than lower doses However, a subsequent 24-week Phase III trial with 502 subjects incorporating intensive diet and exercise showed no statistically significant weight loss compared to placebo, leading to development termination in 2007
Orders placed before 4pm on business days are dispatched the same day, with delivery typically taking 23 business days within the UK
Disclosure of interest: Lukas Mayer-Suess, Lukas Scherer, Stephanie Mangesius, Stefan Kiechl, Elke R
In rodent studies, BPC-157 has been shown to accelerate tendon and ligament repair, safeguard the gut lining, and reduce inflammation, according to the Journal of Physiology and Pharmacology review, 2018
How to avoid it: Recognize that 5-Amino-1MQ is a small-molecule enzyme inhibitor
Before your treatment, you may experience fatigue, sluggish metabolism, difficulty losing weight, and low energy levels
